Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
Xiaoyaosan reactivates the muscle-brain axis via FNDC5/Irisin to ameliorate LPS-induced depression.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yan Peiting, Zheng Yantao, Li Junjie, Wu Chaofeng, Liu Zepeng, Huang Antai, Li Siying, Li Jun, Zeng Qiuxiang, Huang Shaohui, Gao Chong, Gao Lei, Dong Zhaoyang
Аннотация
BACKGROUND: The muscle-brain axis is critical in neuropsychiatric disorders. However, its role in the antidepressant mechanism of Xiaoyaosan (XYS) remains unclear. This study explored whether XYS exerts antidepressant effects by modulating the muscle FNDC5/Irisin-mediated muscle-brain axis to restore hippocampal synaptic plasticity.
METHODS: LPS-induced mouse model was established for in vivo evaluation. In vitro, siRNA knockdown in C2C12-HT22 Transwell co-culture system was used to investigate the involvement of FNDC5/Irisin signaling in muscle-neuron communication. Neuromuscular organoids were established as a three-dimensional platform to model key features of muscle-neuron interactions. Untargeted metabolomics, immunohistochemistry, immunofluorescence, Western blotting, and ELISA were performed.
RESULTS: XYS dose-dependently ameliorated LPS-induced depressive-like behaviors, restored muscle fiber integrity, and reversed hippocampal neuronal loss and synaptic deficits. Metabolomics analysis showed that XYS was associated with normalized metabolite profiles associated with β-alanine and taurine metabolism in the hippocampus and PPAR signaling pathway in the muscle. XYS was also associated with activation of the muscle PPARγ/PGC-1α/FNDC5/Irisin signaling pathway, accompanied by increased circulating Irisin levels and upregulation of hippocampal BDNF, PSD95, and synaptophysin. siRNA knockdown of FNDC5 attenuated the effects of XYS on Irisin secretion and synaptic marker restoration in co-cultured neurons. In organoids, XYS protected both myotube and neuronal compartments from LPS-induced injury.
CONCLUSION: XYS exerts antidepressant effects, at least in part, through the activation of the muscle PPARγ/PGC-1α/FNDC5/Irisin axis and the restoration of hippocampal BDNF-mediated synaptic plasticity. The present findings support a potential role for FNDC5/Irisin in peripheral-to-central signaling associated with the antidepressant effects of XYS. These findings further suggest that the muscle-brain axis may represent a promising therapeutic target for depression and warrants further investigation.
METHODS: LPS-induced mouse model was established for in vivo evaluation. In vitro, siRNA knockdown in C2C12-HT22 Transwell co-culture system was used to investigate the involvement of FNDC5/Irisin signaling in muscle-neuron communication. Neuromuscular organoids were established as a three-dimensional platform to model key features of muscle-neuron interactions. Untargeted metabolomics, immunohistochemistry, immunofluorescence, Western blotting, and ELISA were performed.
RESULTS: XYS dose-dependently ameliorated LPS-induced depressive-like behaviors, restored muscle fiber integrity, and reversed hippocampal neuronal loss and synaptic deficits. Metabolomics analysis showed that XYS was associated with normalized metabolite profiles associated with β-alanine and taurine metabolism in the hippocampus and PPAR signaling pathway in the muscle. XYS was also associated with activation of the muscle PPARγ/PGC-1α/FNDC5/Irisin signaling pathway, accompanied by increased circulating Irisin levels and upregulation of hippocampal BDNF, PSD95, and synaptophysin. siRNA knockdown of FNDC5 attenuated the effects of XYS on Irisin secretion and synaptic marker restoration in co-cultured neurons. In organoids, XYS protected both myotube and neuronal compartments from LPS-induced injury.
CONCLUSION: XYS exerts antidepressant effects, at least in part, through the activation of the muscle PPARγ/PGC-1α/FNDC5/Irisin axis and the restoration of hippocampal BDNF-mediated synaptic plasticity. The present findings support a potential role for FNDC5/Irisin in peripheral-to-central signaling associated with the antidepressant effects of XYS. These findings further suggest that the muscle-brain axis may represent a promising therapeutic target for depression and warrants further investigation.